Search

everythinglearnresearchcommunity

for

Search:↓

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Vitiligo's impact varies widely, affecting both emotions and social life, not just physical symptoms.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Deformable vesicular carriers improve drug delivery for skin conditions and systemic treatments.

Both rosemary extract and 2% ketoconazole lotions effectively treat seborrheic dermatitis and improve quality of life.

Vaccines work well in Netherton syndrome patients, similar to healthy people.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Early diagnosis of Bloch-Sulzberger Syndrome is crucial to prevent severe complications.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

More research is needed to find the best treatment for dissecting cellulitis of the scalp.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Apremilast shows promise for several skin conditions but needs more research.

Topical treatment is recommended for Folliculitis decalvans in pregnant women.

Micro-injury can help regrow hair and repigment vitiligo by activating specific cells.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

A young man developed a rare, bilateral scalp condition after head trauma, causing hair loss but no neurological or eye issues.

A unique case showed a rare combination of two types of lichen planus on the face.

Systemic steroids temporarily improve severe alopecia areata in children but often lead to relapse.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

The author found the Dermatology Nurses’ Association’s annual meeting valuable for both learning and making friends.

Hidradenitis suppurativa is a chronic skin condition more common in women, linked to genetics and lifestyle factors, and associated with various other health issues.

Adding soybean oil to Nonomuraea dietziae increases production of a beneficial compound by improving metabolism and enzyme systems.

Pluripotent stem cells show promise for treating skin color loss disorders like vitiligo.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.